Kratom Paradise MIT tablets and extract powder in a tropical desert product scene

What Is Oxonol? MGM-15, Mitragynine and the Brand Name

Oxonol is a commercial brand name, not a scientific synonym for MGM-15, 7-OH, or mitragynine. The manufacturer description cited here identifies both MGM-15 and mitragynine in the tablets. That dated formula-level detail is more useful than the front-label name alone.

What the name Oxonol tells you—and what it does not

A brand name identifies a product family. It does not by itself disclose every active ingredient, establish the legal status of those ingredients, or show whether the formula has changed. The manufacturer states that “Oxonol” is its product-line name and describes MGM-15 plus mitragynine in the tablets. Because this is a manufacturer claim, the page and package should be checked for the current formula and date.

What is MGM-15?

DEA's August 26, 2026 Federal Register order gives MGM-15 the common chemical name dihydro-7-hydroxymitragynine. The order describes MGM-15 as a synthetic derivative of 7-hydroxymitragynine and identifies it separately from mitragynine, which naturally occurs in Mitragyna speciosa.

This means “Oxonol contains mitragynine” and “Oxonol contains MGM-15” are not redundant statements. They identify different ingredients within the manufacturer’s described formulation.

What MGM-15 is expected to do in the body

A 2025 study of commercial MGM-labeled tablets found about 10.9 milligrams of MGM-15 per tablet and showed that purified MGM-15 binds human mu- and delta-opioid receptors more strongly than 7-OH. MGM-15 has not been administered in a controlled human study, so there is no reliable clinical conversion, established therapeutic benefit, or well-characterized human safety profile.

Oxonol is marketed for human consumption. The receptor data make impairment, tolerance, dependence, and withdrawal plausible, but no controlled human-administration study establishes a clinical benefit, safe amount, or product-equivalence claim.

Why Oxonol appears in the 7-OH conversation

The manufacturer markets the product in relation to 7-OH, but merchandising language such as “7-OH alternative” is not a chemical classification. DEA's August 26 order scheduled MGM-15, MGM-16, and mitragynine pseudoindoxyl. The proposed threshold for 7-OH remains a separate process. A product can therefore differ from 7-OH while still containing a substance covered by the effective order.

How does the DEA temporary order relate to Oxonol?

The Federal Register order does not use the retail name Oxonol; it expressly names MGM-15. If the formula described by the manufacturer contains MGM-15, that ingredient makes the order relevant. The correct comparison is ingredient-to-substance, not brand-name-to-document-title.

The order took effect August 26, 2026 and is scheduled to remain effective through August 26, 2028 unless extended or made permanent. Formula changes and state or local rules can change the product-level answer, so retain a dated ingredient record and reopen the federal status tracker.

How MIT differs

MIT is the common shorthand for mitragynine, a naturally occurring alkaloid of the kratom plant. MGM-15 is not another label for MIT. DEA’s notice explicitly describes MGM-15 as a synthetic derivative and contrasts it with naturally occurring mitragynine.

Kratom Paradise’s MIT tablets and extract powders are organized around that MIT identity. The listings provide product form, labeled option, count or net weight, and qualified document context. They are not represented as Oxonol, MGM-15, 7-OH, approved drugs, or effect-equivalent replacements.

A practical Oxonol identity check

  1. Read the current ingredient panel, not only the brand name.
  2. Look for MGM-15 and its common name, dihydro-7-hydroxymitragynine.
  3. Record any mitragynine amount separately from the MGM-15 amount.
  4. Keep milligrams per tablet separate from total package amounts.
  5. Check the date of the page, package, lab document, and regulatory source.

Sources and next steps

Review the seller's description of its own Oxonol formula, then compare it with the Federal Register temporary order. For a broader side-by-side, use the Oxonol vs MIT vs 7-OH guide and the dated MGM-15 scheduling update.

Kratom Paradise does not sell Oxonol or MGM-15 products. For product and regulatory education only; not medical or legal advice.

Written By : Kratom Paradise Editorial Team